Citius Pharmaceuticals Inc
F:47N
Citius Pharmaceuticals Inc
F:47N
Price:
3.29
EUR
Market Closed
Market Cap:
€594.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Citius Pharmaceuticals Inc
F:47N
|
US |
|
Sands China Ltd
F:599A
|
MO |
|
H
|
HeidelbergCement AG
XBER:HEI
|
DE |
|
R
|
Resonac Holdings Corp
DUS:SWD
|
JP |
|
Bank of China Ltd
F:W8V
|
CN |
|
B
|
Bank of China Ltd
XMUN:W8V
|
CN |
|
B
|
Bank Central Asia Tbk PT
OTC:PBCRF
|
ID |
|
Piramal Enterprises Ltd
BSE:500302
|
IN |
|
Suncor Energy Inc
TSX:SU
|
CA |
|
BayWa AG
F:BYW
|
DE |
|
COMPUTERSHARE LIMITED
ASX:CPU
|
AU |
|
P
|
PostNL NV
XMUN:TNTC
|
NL |
|
P
|
Persimmon PLC
XMUN:OHP
|
UK |
|
F
|
First Solar Inc
DUS:F3A
|
US |
|
C
|
Concentra Group Holdings Parent Inc
NYSE:CON
|
US |
Wall St Price Targets
47N Price Targets Summary
Citius Pharmaceuticals Inc
Citius Pharmaceuticals Inc
Wall Street analysts forecast 47N stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 47N is 23.96 EUR with a low forecast of 18.98 EUR and a high forecast of 29.59 EUR.
Lowest Forecast
Price Target
18.98
EUR
477% Upside
Average Forecast
Price Target
23.96
EUR
628% Upside
Highest Forecast
Price Target
29.59
EUR
799% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 47N's stock price target?
Price Target
23.96
EUR
23.96
EUR
According to Wall Street analysts, the average 1-year price target for 47N is 23.96 EUR with a low forecast of 18.98 EUR and a high forecast of 29.59 EUR.
